Boston Scientific prices debt offerings
- Boston Scientific (BSX) priced a public offering of $3B in U.S. dollar-denominated senior notes across four tranches, with maturities ranging from 2029 to 2036.
- Separately, the company's indirect wholly owned finance subsidiary, American Medical Systems Europe B.V., priced a €4.25B public offering of euro-denominated notes
KioskNews shows a cleaned-up reading view extracted from the publisher’s page — the original always lives on their site, not ours.